Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8K82

Cryo-EM structure of the yeast 80S ribosome with tigecycline, Not5 and P-site tRNA

This is a non-PDB format compatible entry.
Summary for 8K82
Entry DOI10.2210/pdb8k82/pdb
EMDB information36945
Descriptor18S rRNA, Small ribosomal subunit protein uS3, 40S ribosomal protein S4-A, ... (88 entities in total)
Functional Keywords80s ribosome, tigecycline, antibiotic, ribosome
Biological sourceSaccharomyces cerevisiae
More
Total number of polymer chains85
Total formula weight3288578.86
Authors
Buschauer, R.,Beckmann, R.,Cheng, J. (deposition date: 2023-07-28, release date: 2024-07-10, Last modification date: 2024-11-06)
Primary citationLi, X.,Wang, M.,Denk, T.,Buschauer, R.,Li, Y.,Beckmann, R.,Cheng, J.
Structural basis for differential inhibition of eukaryotic ribosomes by tigecycline.
Nat Commun, 15:5481-5481, 2024
Cited by
PubMed Abstract: Tigecycline is widely used for treating complicated bacterial infections for which there are no effective drugs. It inhibits bacterial protein translation by blocking the ribosomal A-site. However, even though it is also cytotoxic for human cells, the molecular mechanism of its inhibition remains unclear. Here, we present cryo-EM structures of tigecycline-bound human mitochondrial 55S, 39S, cytoplasmic 80S and yeast cytoplasmic 80S ribosomes. We find that at clinically relevant concentrations, tigecycline effectively targets human 55S mitoribosomes, potentially, by hindering A-site tRNA accommodation and by blocking the peptidyl transfer center. In contrast, tigecycline does not bind to human 80S ribosomes under physiological concentrations. However, at high tigecycline concentrations, in addition to blocking the A-site, both human and yeast 80S ribosomes bind tigecycline at another conserved binding site restricting the movement of the L1 stalk. In conclusion, the observed distinct binding properties of tigecycline may guide new pathways for drug design and therapy.
PubMed: 38942792
DOI: 10.1038/s41467-024-49797-7
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon